Loading...
XJPX
4202
Market cap2.48bUSD
Sep 19, Last price  
1,385.00JPY
1D
-1.42%
1Q
16.29%
Jan 2017
7.36%
Name

Daicel Corp

Chart & Performance

D1W1MN
P/E
7.42
P/S
0.63
EPS
186.63
Div Yield, %
3.75%
Shrs. gr., 5y
-3.23%
Rev. gr., 5y
7.28%
Revenues
586.53b
+5.10%
335,520,000,000381,422,000,000416,989,000,000377,979,000,000320,243,000,000353,684,000,000341,942,000,000358,513,000,000413,786,000,000443,775,000,000449,878,000,000440,061,000,000462,956,000,000464,859,000,000412,826,000,000393,568,000,000467,937,000,000538,026,000,000558,056,000,000586,531,000,000
Net income
49.48b
-11.38%
14,220,000,00017,438,000,00013,675,000,0001,296,000,00011,069,000,00016,802,000,00011,827,000,00015,372,000,00022,843,000,00031,252,000,00040,313,000,00043,198,000,00037,062,000,00035,301,000,0004,978,000,00019,713,000,00031,254,000,00040,682,000,00055,834,000,00049,481,000,000
CFO
93.41b
+21.73%
32,780,000,00025,534,000,00049,275,000,00040,165,000,00066,445,000,00053,428,000,00034,000,000,00044,480,000,00044,777,000,00057,412,000,00065,419,000,00086,168,000,00066,888,000,00058,523,000,00057,193,000,00057,869,000,00042,993,000,00026,847,000,00076,729,000,00093,406,000,000
Dividend
Sep 29, 20250 JPY/sh

Profile

Daicel Corporation engages in the medical/healthcare, smart, safety, materials, engineering plastics, and other businesses in Japan, China, and internationally. The company offers 1,3-Butylene glycol and polyglycerin for cosmetics; chiral and achiral columns/stationary phases, analytical tools, analytical/purification/synthesis/formulation services, chiral and bio reagents, analytical standards, and DNA and RNA-based probes; triacetylcellulose, high performance film, solvent for electronic materials, polymer for resist, semiconductor process cleaning agent, optical parts and lens unit, silver nanoparticle ink, and organic semiconductor devices; and inflators, pyro-fuse, and safety device for non-mobility products; and acetic acid and derivatives, cellulose acetate, acetate tow, cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines. It also provides ceramide derived from konjac root, equol derived from soybeans, ß-cryptoxanthin derived from citrus unshiu, and lactobionic acid derived from milk; DiSPERZiSTA, a dispersible filler for dietary supplement tablet; and MOiSTCARM, a make granules easy to swallow. In addition, the company offers engineering plastics and plastic compound products, high performance polymer, functional sheets, formed trays, and packaging films; water treatment systems and diffusers, such as UF membrane modules, ultra-fine bubble membrane diffusers, and E mizu showers. Its products are used in transportation, electronics, medical care, personal care, everyday life, and environment and energy applications. The company was formerly known as Daicel Chemical Industries, Ltd. and changed its name to Daicel Corporation in October 2011. Daicel Corporation was incorporated in 1919 and headquartered in Osaka, Japan.
URL
https://www.daicel.com/
IPO date
May 16, 1949
Employees
11,207
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
586,531,000
5.10%
558,056,000
3.72%
538,026,000
14.98%
Cost of revenue
421,785,000
496,770,000
491,749,000
Unusual Expense (Income)
NOPBT
164,746,000
61,286,000
46,277,000
NOPBT Margin
28.09%
10.98%
8.60%
Operating Taxes
15,022,000
19,487,000
13,326,000
Tax Rate
9.12%
31.80%
28.80%
NOPAT
149,724,000
41,799,000
32,951,000
Net income
49,481,000
-11.38%
55,834,000
37.24%
40,682,000
30.17%
Dividends
(15,170,000)
(12,859,000)
(10,651,000)
Dividend yield
4.29%
3.01%
3.64%
Proceeds from repurchase of equity
(15,000,000)
(15,000,000)
46,519,000
BB yield
4.24%
3.51%
-15.88%
Debt
Debt current
72,898,000
85,049,000
109,009,000
Long-term debt
208,021,000
221,141,000
211,766,000
Deferred revenue
8,000
6,098,000
Other long-term liabilities
9,369,000
13,889,000
5,002,000
Net debt
159,125,000
143,147,000
137,704,000
Cash flow
Cash from operating activities
93,406,000
76,729,000
26,847,000
CAPEX
(72,342,000)
(69,208,000)
(51,923,000)
Cash from investing activities
(47,869,000)
(55,374,000)
(44,093,000)
Cash from financing activities
(48,855,000)
(52,373,000)
19,956,000
FCF
165,139,000
(29,001,000)
(33,982,000)
Balance
Cash
65,142,000
73,183,000
93,840,000
Long term investments
56,652,000
89,860,000
89,231,000
Excess cash
92,467,450
135,140,200
156,169,700
Stockholders' equity
391,205,000
390,753,000
551,237,000
Invested Capital
572,860,550
556,596,800
477,852,300
ROIC
26.51%
8.08%
7.47%
ROCE
24.36%
8.57%
7.14%
EV
Common stock shares outstanding
272,708
282,617
292,957
Price
1,297.50
-14.30%
1,514.00
51.40%
1,000.00
22.40%
Market cap
353,838,066
-17.30%
427,882,118
46.06%
292,957,000
19.48%
EV
528,015,066
586,993,118
671,107,000
EBITDA
206,119,000
94,989,000
77,852,000
EV/EBITDA
2.56
6.18
8.62
Interest
1,983,000
1,668,000
1,432,000
Interest/NOPBT
1.20%
2.72%
3.09%